Capecitabine and oxaliplatin for advanced esophagogastric cancer

David Cunningham, Naureen Starling, Sheela Rao, Timothy Iveson, Marianne Nicolson, Fareeda Coxon, Gary Middleton, Francis Daniel, Jacqueline Oates, Andrew Richard Norman, Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom

Research output: Contribution to journalArticlepeer-review

1671 Citations (Scopus)


We evaluated capecitabine (an oral fluoropyrimidine) and oxaliplatin (a platinum compound) as alternatives to infused fluorouracil and cisplatin, respectively, for untreated advanced esophagogastric cancer.
Original languageEnglish
Pages (from-to)36-46
Number of pages11
JournalThe New England Journal of Medicine
Issue number1
Publication statusPublished - 2008


Dive into the research topics of 'Capecitabine and oxaliplatin for advanced esophagogastric cancer'. Together they form a unique fingerprint.

Cite this